Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H27NO4 |
| Molecular Weight | 333.422 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(O)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(O)=O
InChI
InChIKey=IUMHIIXPABZGRF-BZUAXINKSA-N
InChI=1S/C19H27NO4/c1-19(2,24)15-10-8-14(9-11-15)17(21)20-16(18(22)23)12-13-6-4-3-5-7-13/h3-7,14-16,24H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t14-,15-,16-/m1/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Hypoglycemia due to nateglinide administration in diabetic patient with chronic renal failure. | 2003 Mar |
|
| Prediction of the metabolic interaction of nateglinide with other drugs based on in vitro studies. | 2007 Dec |
|
| Inhibition of human liver microsomal CYP by nateglinide. | 2010 May |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
0I0E1W80TU
Created by
admin on Sat Dec 16 08:47:13 GMT 2023 , Edited by admin on Sat Dec 16 08:47:13 GMT 2023
|
PRIMARY | |||
|
91511538
Created by
admin on Sat Dec 16 08:47:13 GMT 2023 , Edited by admin on Sat Dec 16 08:47:13 GMT 2023
|
PRIMARY | |||
|
183996-82-9
Created by
admin on Sat Dec 16 08:47:13 GMT 2023 , Edited by admin on Sat Dec 16 08:47:13 GMT 2023
|
PRIMARY |
PARENT (METABOLITE)
